Showing results (201-210 of 672) with videos related to
Sort By:
Pageof 68
Pharmacopsychiatry|July 1, 1995
Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementiaW E Müller, E Mutschler, P RiedererClinical Neurology and Neurosurgery|January 1, 1979
Distinction between benign and malignant type of Parkinson's diseaseW Birkmayer, P Riederer, B H YoudimEuropean Journal of Pharmacology|June 5, 1992
The molecular pharmacology of L-deprenylM Gerlach, P Riederer, M B YoudimJournal of Neural Transmission|January 1, 1987
HPLC analysis of somatostatin related peptides in putamen of Huntington's disease patientsG Sperk, G P Reynolds, P RiedererClinical Neuropathology|January 1, 1982
Adult GM2 gangliosidosis masquerading as slowly progressive muscular atrophy: motor neuron disease phenotypeK Jellinger, A P Anzil, D Seemann, et al.Acta Histochemica. Supplementband|January 1, 1992
Type VIII collagen in the normal and diseased human brainW Paulus, E H Sage, K Jellinger, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 2, 2001
Neurotransmission in HIV associated dementia: a short reviewE Koutsilieri, V ter Meulen, P RiedererNeuroscience and Biobehavioral Reviews|July 1, 1997
Dopamine/glutamate interactions in Parkinson's diseaseK W Lange, J Kornhuber, P RiedererBrain Research|June 12, 1989
Regional distribution of [3H]MK-801 binding sites in the human brainJ Kornhuber, F Mack-Burkhardt, P RiedererJournal of Molecular Medicine (Berlin, Germany)|July 1, 1996
The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processesK P Lesch, A Heils, P RiedererPageof 68